Andrew Taylor to Defibrillators, Implantable
This is a "connection" page, showing publications Andrew Taylor has written about Defibrillators, Implantable.
Connection Strength
3.488
-
Gutman SJ, Taylor AJ. Reply to letter by Frey et al. regarding the article: Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar. Eur Heart J. 2019 09 14; 40(35):2997.
Score: 0.678
-
Gutman SJ, Costello BT, Papapostolou S, Voskoboinik A, Iles L, Ja J, Hare JL, Ellims A, Kistler PM, Marwick TH, Taylor AJ. Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar. Eur Heart J. 2019 02 07; 40(6):542-550.
Score: 0.651
-
Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011 Feb 15; 57(7):821-8.
Score: 0.374
-
Taylor AJ, Elsik M, Broughton A, Cherayath J, Leet A, Wong C, Iles L, Butler M, Pfluger H. Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy. Europace. 2010 May; 12(5):708-13.
Score: 0.350
-
Paratz ED, Stub D, Sutherland N, Gutman S, La Gerche A, Mariani J, Taylor A, Ellims A. Response to: Regard to assessing agreement between two raters with kappa statistics. Int J Cardiol. 2024 Jun 01; 404:131978.
Score: 0.232
-
Paratz ED, Stub D, Sutherland N, Gutman S, La Gerche A, Mariani J, Taylor A, Ellims A. The challenge of risk stratification in hypertrophic cardiomyopathy: Clinical, genetic and imaging insights from a quaternary referral centre. Int J Cardiol. 2024 Jan 15; 395:131416.
Score: 0.225
-
Xu K, Sengupta J, Casey S, Peltier J, Stahl W, Peterson N, Settimi D, Taylor A, Kippola J, Steele E, Hauser R. Magnetic field interactions between current consumer electronics and cardiac implantable electronic devices. J Interv Card Electrophysiol. 2022 Oct; 65(1):133-139.
Score: 0.204
-
Captur G, Manisty CH, Raman B, Marchi A, Wong TC, Ariga R, Bhuva A, Ormondroyd E, Lobascio I, Camaioni C, Loizos S, Bonsu-Ofori J, Turer A, Zaha VG, Augutsto JB, Davies RH, Taylor AJ, Nasis A, Al-Mallah MH, Valentin S, Perez de Arenaza D, Patel V, Westwood M, Petersen SE, Li C, Tang L, Nakamori S, Nezafat R, Kwong RY, Ho CY, Fraser AG, Watkins H, Elliott PM, Neubauer S, Lloyd G, Olivotto I, Nihoyannopoulos P, Moon JC. Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical Care. JACC Cardiovasc Imaging. 2021 11; 14(11):2123-2134.
Score: 0.191
-
Gutman SJ, Costello BT, Papapostolou S, Iles L, Ja J, Hare JL, Ellims A, Marwick TH, Taylor AJ. Impact of sex, socio-economic status, and remoteness on therapy and survival in heart failure. ESC Heart Fail. 2019 10; 6(5):944-952.
Score: 0.171
-
Voskoboinik A, Bloom J, Taylor A, Mariani J. Early Implantation of Primary Prevention Implantable Cardioverter Defibrillators for Patients with Newly Diagnosed Severe Nonischemic Cardiomyopathy. Pacing Clin Electrophysiol. 2016 Sep; 39(9):992-8.
Score: 0.136
-
Zaman S, Taylor AJ, Stiles M, Chow C, Kovoor P. Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction (PROTECT-ICD): Trial Protocol, Background and Significance. Heart Lung Circ. 2016 Nov; 25(11):1055-1062.
Score: 0.134
-
Taylor AJ, Ellims A, Lew PJ, Murphy B, Pally S, Younie S. Impact of cardiac magnetic resonance imaging on cardiac device and surgical therapy: a prospective study. Int J Cardiovasc Imaging. 2013 Apr; 29(4):855-64.
Score: 0.109
-
McLELLAN AJ, Ellims AH, Prabhu S, Voskoboinik A, Iles LM, Hare JL, Kaye DM, Macciocca I, Mariani JA, Kalman JM, Taylor AJ, Kistler PM. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy. J Cardiovasc Electrophysiol. 2016 05; 27(5):571-80.
Score: 0.033